IceCure Medical Ltd. has announced a Special General Meeting of Shareholders on August 6, 2026, to vote on proposed amendments to the terms of existing warrants, following an agreement with a warrant holder on June 17, 2026. Shareholders of record as of July 9, 2026, will be entitled to vote. IceCure Medical Ltd. is a medical technology company specializing in in-office cryoablation technology for in-office prostate cancer treatment.
